ImmuCell Corporation Current Income Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Current Income Tax Expense (Benefit) of $10.06 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2025-03-28
- ImmuCell Corporation current income tax expense (benefit) for the quarter ending 2023-06-30 was $1.52K, a 32.84% increase year-over-year.
- ImmuCell Corporation current income tax expense (benefit) for the quarter ending 2023-03-31 was $1.52K, a 32.84% increase year-over-year.
- ImmuCell Corporation current income tax expense (benefit) for the quarter ending 2022-12-31 was $1.51K, a 34.58% increase year-over-year.
- ImmuCell Corporation current income tax expense (benefit) for the quarter ending 2022-09-30 was $3.87K, a 51.92% decline year-over-year.
- ImmuCell Corporation current income tax expense (benefit) for fiscal 2024 was $10.06K, a 117.33% increase from fiscal 2023.
- ImmuCell Corporation current income tax expense (benefit) for fiscal 2023 was $4.63K, a 39.69% decline from fiscal 2022.
- ImmuCell Corporation current income tax expense (benefit) for fiscal 2022 was $7.67K, a 16.29% decline from fiscal 2021.
- ImmuCell Corporation current income tax expense (benefit) for fiscal 2021 was $9.16K, a 103.85% increase from fiscal 2020.
| Period end | Current Income Tax Expense (Benefit) 3 month | Current Income Tax Expense (Benefit) 6 month | Current Income Tax Expense (Benefit) 9 month | Current Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $10.06K 10-K · filed 2025-03-28 | |||
| 2023-12-31 | $4.63K 10-K · filed 2025-03-28 | |||
| 2023-06-30 | $1.52K 10-Q · filed 2023-08-10 | $3.05K 10-Q · filed 2023-08-10 | $4.56K derived: sum of 3 quarters · filed 2024-04-01 | $8.43K derived: sum of 4 quarters · filed 2024-04-01 |
| 2023-03-31 | $1.52K 10-Q · filed 2023-05-11 | $3.04K derived: sum of 2 quarters · filed 2024-04-01 | $6.90K derived: sum of 3 quarters · filed 2024-04-01 | $8.05K derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-12-31 | $1.51K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $5.38K derived: sum of 2 quarters · filed 2024-04-01 | $6.53K derived: sum of 3 quarters · filed 2024-04-01 | $7.67K 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.87K 10-Q · filed 2022-11-21 | $5.01K derived: sum of 2 quarters · filed 2023-08-10 | $6.16K 10-Q · filed 2022-11-21 | $7.29K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | $1.15K 10-Q · filed 2023-08-10 | $2.29K 10-Q · filed 2023-08-10 | $3.42K derived: sum of 3 quarters · filed 2023-08-10 | $11.46K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.15K 10-Q · filed 2023-05-11 | $2.27K derived: sum of 2 quarters · filed 2023-05-11 | $10.31K derived: sum of 3 quarters · filed 2023-05-11 | $10.31K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $9.16K derived: sum of 2 quarters · filed 2023-03-29 | $9.16K derived: sum of 3 quarters · filed 2023-03-29 | $9.16K 10-K · filed 2023-03-29 |
| 2021-09-30 | $8.04K 10-Q · filed 2022-11-21 | $8.04K derived: sum of 2 quarters · filed 2022-11-21 | $8.04K 10-Q · filed 2022-11-21 | -$2.09K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $0.00 10-Q/A · filed 2022-11-21 | $0.00 10-Q/A · filed 2022-11-21 | -$10.14K derived: sum of 3 quarters · filed 2022-11-21 | -$10.14K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $0.00 10-Q/A · filed 2022-11-21 | -$10.14K derived: sum of 2 quarters · filed 2022-11-21 | -$10.14K derived: sum of 3 quarters · filed 2022-11-21 | -$10.14K derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | -$10.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$10.14K derived: sum of 2 quarters · filed 2022-03-30 | -$10.14K derived: sum of 3 quarters · filed 2022-03-30 | $4.50K 10-K · filed 2022-03-30 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $14.63K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $14.63K 10-Q · filed 2021-08-12 | ||
| 2017-12-31 | $14.48K 10-K · filed 2018-03-29 | |||
| 2016-12-31 | $13.59K 10-K · filed 2018-03-29 | |||
| 2015-12-31 | $3.15K 10-K · filed 2017-03-30 | |||
| 2014-12-31 | $252.00 10-K · filed 2016-03-25 | |||
| 2013-12-31 | $301.00 10-K · filed 2016-03-25 | |||
| 2012-12-31 | $708.00 10-K · filed 2015-03-26 | |||
| 2011-12-31 | $510.00 10-K · filed 2014-03-26 | |||
| 2010-12-31 | $144.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |